CD4 and viral infectious disease: In conclusion, fractional doses of the 17D-213 yellow fever vaccine are safe, effective, and immunologically non-inferior to standard doses in HIV-infected individuals on antiretroviral therapy with CD4+ T-cell counts of at least 200 cells per mL.